Sanofi pays J&J $175M for late-phase E. coli shot, pushing deeper into vaccines as...

cafead

Administrator
Staff member
  • cafead   Oct 03, 2023 at 10:32: AM
via As Johnson & Johnson retreats from the vaccine sector, Sanofi is gambling $175 million on the healthcare giant's late-phase E. coli vaccine.

article source